Literature DB >> 23370999

Treatment of osteoarthritis of the first carpometacarpal joint by resection-suspension-interposition arthoplasty using the split abductor pollicis longus tendon.

P S Harenberg1, M G Jakubietz, R G Jakubietz, K Schmidt, R H Meffert.   

Abstract

OBJECTIVE: Reduction of pain and gain of functionality in symptomatic osteoarthritis of the first carpometacarpal joint. INDICATIONS: Idiopathic, rheumatic, or posttraumatic osteoarthritis of the first carpometacarpal joint. RELATIVE CONTRAINDICATIONS: Poor general condition, poor condition of the hand's soft tissue/skin, chronic regional pain syndrome, current or recent infections of the hand, heavy manual labor (decision on a by-case basis). SURGICAL TECHNIQUE: Supine position, hand pronated or slightly tilted. Upper arm tourniquet (Esmarch's method). Loupe magnification. Incision over the first extensor compartment. Exposure and incision of the thumb's basal joint. Resection of the trapezium. Exposure of the abductor pollicis longus (APL) tendon. Longitudinal split of the tendon harvesting the distally based ulnar part of the tendon. The split APL tendon is wrapped around the flexor carpi radialis (FCR) muscle tendon, suturing it to the tendon and back to itself. The rest of the split APL tendon is placed into the gap between the scaphoid and the first metacarpal bone, which is followed by wound closure. POSTOPERATIVE MANAGEMENT: Plaster cast (thumb abduction splint) for 4 weeks. Stable commercially available wrist brace for at least 2 more weeks.
RESULTS: There were no significant differences between the FCR arthroplasty (Epping's method) and the APL arthroplasty (Wulle's technique) regarding pain (visual analog scale), disability/usability (DASH score), or range of motion. Patients who had undergone APL arthroplasty showed significantly better grip and pinch strength. Furthermore, the operating time was significantly shorter and scars were significantly smaller in APL arthroplasty.

Entities:  

Mesh:

Year:  2013        PMID: 23370999     DOI: 10.1007/s00064-011-0082-2

Source DB:  PubMed          Journal:  Oper Orthop Traumatol        ISSN: 0934-6694            Impact factor:   1.154


  6 in total

1.  Abductor pollicis longus tendon arthroplasty for treatment of arthrosis in the first carpometacarpal joint.

Authors:  R Sigfusson; G Lundborg
Journal:  Scand J Plast Reconstr Surg Hand Surg       Date:  1991

2.  Development of an upper extremity outcome measure: the DASH (disabilities of the arm, shoulder and hand) [corrected]. The Upper Extremity Collaborative Group (UECG)

Authors:  P L Hudak; P C Amadio; C Bombardier
Journal:  Am J Ind Med       Date:  1996-06       Impact factor: 2.214

3.  [Long-term results after resection arthroplasty in patients with arthrosis of the thumb carpometacarpal joint: comparison of abductor pollicis longus and flexor carpi radialis tendon suspension].

Authors:  M Rab; A Gohritz; T Gohla; H Krimmer; U Lanz
Journal:  Handchir Mikrochir Plast Chir       Date:  2006-04       Impact factor: 1.018

4.  Tendon interposition arthroplasty of the first carpo-metacarpal joint.

Authors:  A Weilby
Journal:  J Hand Surg Br       Date:  1988-11

5.  Tendon interposition arthroplasty for degenerative arthritis of the trapeziometacarpal joint of the thumb.

Authors:  R G Eaton; S Z Glickel; J W Littler
Journal:  J Hand Surg Am       Date:  1985-09       Impact factor: 2.230

6.  [Abductor pollicis longus-repair in treating basal thumb joint arthrosis].

Authors:  C Wulle
Journal:  Handchir Mikrochir Plast Chir       Date:  1993-09       Impact factor: 1.018

  6 in total
  2 in total

Review 1.  [Resection arthoplasty of the trapezium with ligament reconstruction and tendon interposition and variations].

Authors:  Martin Franz Langer; Jörg Gerhard Grünert; Frank Unglaub; Martin Richter; Jörg van Schoonhoven; Simon Oeckenpöhler
Journal:  Oper Orthop Traumatol       Date:  2021-06-09       Impact factor: 1.154

Review 2.  Surgical treatment of trapeziometacarpal joint arthritis: a historical perspective.

Authors:  Vincent R Hentz
Journal:  Clin Orthop Relat Res       Date:  2014-04       Impact factor: 4.176

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.